Survivorship program including long-term toxicities and quality-of-life development over 10 years in a randomized trial in operable stage III non-small-cell lung cancer (ESPATUE).

Autor: Schulte C; Department of Medical Oncology, University Hospital and Ruhrlandklinik, West German Cancer Center, Essen, Germany., Gauler T; Department of Radiation Oncology, University Hospital Essen, Essen, Germany., Pöttgen C; Department of Radiation Oncology, University Hospital Essen, Essen, Germany., Friedel G; Department of Thoracic Surgery, Universitätsklinikum Tübingen, Universität Tübingen, Tübingen, Germany., Kopp HG; Department of Medical Oncology, Robert-Bosch Krankenhaus, Stuttgart, Germany., Fischer B; Department of Pulmonology, University Medicine Mainz, Mainz, Germany., Schmidberger H; Department of Radiation Oncology, University Medicine Mainz, Mainz, Germany., Kimmich M; Robert Bosch Center for Tumor Diseases (RBCTD), Robert-Bosch Hospital, Stuttgart, Germany., Budach W; Department of Radiation Oncology, University Medicine Düsseldorf, Düsseldorf, Germany., Cordes S; Department of Pulmonology, West German Cancer Center, Essen, Germany., Wienker J; Department of Pulmonology, West German Cancer Center, Essen, Germany., Metzenmacher M; Department of Medical Oncology, University Hospital and Ruhrlandklinik, West German Cancer Center, Essen, Germany., de Los Rios RH; Klinik für Strahlentherapie, Evangelisches Krankenhaus Gelsenkirchen, Gelsenkirchen, Germany., Spengler W; Department of Pulmonology, University Medicine Tuebingen, Tübingen, Germany., De Ruysscher D; Department of Radiation Oncology (Maastro), Maastricht University Medical Center, GROW School, Maastricht, The Netherlands., Belka C; Department of Radiation Oncology, University Medicine Munich, Munich, Germany., Welter S; Department of Thoracic Surgery, Lungenklinik Hemer, Hemer, Germany., Luetke-Brintrup D; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany., Guberina M; Department of Radiation Oncology, University Hospital Essen, Essen, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Germany., Oezkan F; Department of Pulmonology, Interventional Bronchology, West German Cancer Center, Essen, Germany., Darwiche K; Department of Pulmonology, Interventional Bronchology, West German Cancer Center, Essen, Germany., Schuler M; Department of Medical Oncology, University Hospital and Ruhrlandklinik, West German Cancer Center, Essen, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Germany.; Department of Thoracic Oncology, Ruhrlandklinik, Essen, Germany., Jöckel KH; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany., Aigner C; Department of Thoracic Surgery, Ruhrlandklinik Essen, West German Cancer Center, Essen, Germany., Stamatis G; Department of Thoracic Surgery, Ruhrlandklinik Essen, West German Cancer Center, Essen, Germany., Stuschke M; Department of Radiation Oncology, University Hospital Essen, Essen, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Germany., Eberhardt WEE; Department of Medical Oncology, University Hospital and Ruhrlandklinik, West German Cancer Center, Essen, Germany.; Department of Thoracic Oncology, Ruhrlandklinik, Essen, Germany.

Publikováno v: International journal of cancer [Int J Cancer] 2025 Jan 01; Vol. 156 (1), pp. 154-163. Date of Electronic Publication: 2024 Aug 28.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer

Autor: Cohen, E.E.W. ^*, Licitra, L.F., Burtness, B., Fayette, J., Gauler, T., Clement, P.M., Grau, J.J., del Campo, J.M., Mailliez, A., Haddad, R.I., Vermorken, J.B., Tahara, M., Guigay, J., Geoffrois, L., Merlano, M.C., Dupuis, N., Krämer, N., Cong, X.J., Gibson, N., Solca, F., Ehrnrooth, E., Machiels, J.-P.H.

Publikováno v: In Annals of Oncology October 2017 28(10):2526-2532

Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment-Comparison with Stage III Disease.

Autor: Guberina M; Department of Radiotherapy, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany.; National Center for Tumor Diseases (NCT) West, Campus Essen, 45147 Essen, Germany., Pöttgen C; Department of Radiotherapy, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany., Guberina N; Department of Radiotherapy, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany.; National Center for Tumor Diseases (NCT) West, Campus Essen, 45147 Essen, Germany., Hoffmann C; Department of Radiotherapy, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany., Wiesweg M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany.; Division of Thoracic Oncology, West German Cancer Center, University Medicine Essen-Ruhrlandklinik, 45239 Essen, Germany., Richlitzki C; Department of Radiotherapy, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany.; Department of Radiation Oncology, University Hospital, LMU Munich, 81377 Munich, Germany., Metzenmacher M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany., Aigner C; Department of Thoracic Surgery and Thoracic Endoscopy, West German Cancer Center, University Medicine Essen-Ruhrlandklinik, University Duisburg-Essen, 45239 Essen, Germany.; Department of Thoracic Surgery, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria., Bölükbas S; Department of Thoracic Surgery and Thoracic Endoscopy, West German Cancer Center, University Medicine Essen-Ruhrlandklinik, University Duisburg-Essen, 45239 Essen, Germany., Gauler T; Department of Radiotherapy, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany., Eberhardt WEE; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany.; Division of Thoracic Oncology, West German Cancer Center, University Medicine Essen-Ruhrlandklinik, 45239 Essen, Germany., Forsting M; Institute of Diagnostic, Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany., Herrmann K; National Center for Tumor Diseases (NCT) West, Campus Essen, 45147 Essen, Germany.; Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany., Theegarten D; Institute of Pathology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany., Darwiche K; Section of Interventional Pneumology, Department of Pulmonary Medicine, West German Cancer Center, University Medicine Essen-Ruhrlandklinik, University Duisburg-Essen, 45239 Essen, Germany., Jendrossek V; Institute for Cell Biology (Cancer Research), University Hospital Essen, 45147 Essen, Germany., Stuschke M; Department of Radiotherapy, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany.; National Center for Tumor Diseases (NCT) West, Campus Essen, 45147 Essen, Germany., Schuler M; National Center for Tumor Diseases (NCT) West, Campus Essen, 45147 Essen, Germany.; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany.; Division of Thoracic Oncology, West German Cancer Center, University Medicine Essen-Ruhrlandklinik, 45239 Essen, Germany.

Publikováno v: Cancers [Cancers (Basel)] 2024 Mar 17; Vol. 16 (6). Date of Electronic Publication: 2024 Mar 17.

EP.07A.19 Impact of Preoperative Pulmonary Function on Survival Following Lobectomy for Stage I and II Lung Cancer

Autor: Grapatsas, K., Doerr, F., Oezkan, F., Baldes, N., Darwiche, K., Theegarten, D., Eberhardt, W., Gauler, T., Stuschke, M., Hautzel, H., Herrmann, K., Taube, C., Forsting, M., Schuler, M., Bölükbas, S.

Publikováno v: In Journal of Thoracic Oncology October 2024 19(10) Supplement:S531-S531